← Back to all signals
RESEARCH PAPER ANALYSIS

A Methodological Review of Voice Acoustic Parameters, with Emphasis on Vocal Tremor: Definitions, Computation, and Software Tools.

This paper is a structured methodological review of acoustic parameters for characterizing vocal tremor, comparing definitions, computations, and implementations across common voice-analysis software and advocating a multidimensional parameter framework.

PMID41951462
JournalJournal of voice : official journal of the Voice Foundation
Publication Date2026-04-07
Ingested2026-04-28 08:58 PM
EXECUTIVE SUMMARY

What the AI sees

This paper is a structured methodological review of acoustic parameters for characterizing vocal tremor, comparing definitions, computations, and implementations across common voice-analysis software and advocating a multidimensional parameter framework.

WHY IT MATTERS

Research significance

Standardizing and clarifying voice-acoustic features can improve development and reliability of speech-based biomarkers for Parkinson's disease diagnosis and monitoring, aiding patient stratification and outcome measurement in trials, though it offers little direct insight into therapeutic…

ABSTRACT

Source abstract

UNLABELLED: Vocal tremor is a relevant feature in several neurological voice disorders, including essential vocal tremor and Parkinson's disease. However, its acoustic characterization remains challenging due to the complex and often nonstationary nature of voice signals. In this study, we present a structured methodological review of acoustic parameters used in voice analysis, with particular emphasis on vocal tremor, aiming to organize and clarify their conceptual interpretation, computational formulation, and implementation in widely adopted voice analysis software. Illustrative examples based on sustained vowel samples from healthy and pathological voices are included solely to exemplify the behavior of selected parameters and to support the methodological discussion, rather than to constitute the primary focus of the study. METHOD: This study adopts a structured methodological review approach. Relevant literature on voice acoustic analysis, vocal tremor, and Parkinson's disease was surveyed, focusing on studies that define, compute, and apply acoustic parameters for sustained vowel analysis. Acoustic features were selected based on their recurrent use in the literature, clinical relevance to neurological voice disorders, and clarity of conceptual and mathematical definition, encompassing conventional perturbation and noise measures, nonlinear parameters, and a dedicated set of vocal tremor features. The computational formulations of these parameters were systematically analyzed and contrasted across commonly used voice analysis software packages, including Multi-Dimensional Voice Program, Praat, and VoxMetria. A descriptive and comparative analysis was conducted to identify conceptual ambiguities, differences in implementation, and practical implications across parameters and software tools. Illustrative examples from healthy and pathological voices were included solely to support the methodological discussion. RESULTS: The comparative and descriptive analysis revealed substantial variability in the conceptual definitions and computational formulations of acoustic parameters across the reviewed literature and voice analysis software. Differences were observed in parameter naming, mathematical implementation, and underlying signal assumptions, particularly for vocal tremor-related features. The analysis also highlighted inconsistencies in the availability and calculation of tremor parameters across commonly used software tools. Illustrative vowel examples demonstrated distinct behaviors among parameter groups when applied to healthy and pathological voices. CONCLUSIONS: This work emphasizes that acoustic characterization of vocal tremor benefits from a multidimensional framework that integrates traditional, tremor-specific, and nonlinear parameters. By clarifying conceptual definitions and computational aspects, the study provides a reference-oriented perspective that supports consistent interpretation of results and informed application of acoustic parameters in both research and clinical contexts.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity. International immunopharmacology 91.0 2 Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications. Cells 91.0 3 Flavonoids improve neurotransmitters for Parkinson's treatment: mechanism and therapeutic potential. Frontiers in pharmacology 88.0 4 Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. Neurology international 78.0 5 The Gut Microbiota in Parkinson's Disease: Mechanistic Insights into Microbial-Host Interactions. Microorganisms 85.0 6 Linking inflammation, metabolic dysfunction, and neurodegeneration: a comprehensive review of TLR2 pathways in type 2 diabetes. Frontiers in clinical diabetes and healthcare 80.0 7 Neuroprotective effects of GLP-2 and a GLP-2/GIP dual receptor agonist in an MPTP-induced mouse model of Parkinson's disease. Peptides 86.0 8 TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation. Nature communications 91.5 9 Lipid Metabolism and Neurodegeneration: Mechanistic Insights and Therapeutic Targets. Ageing research reviews 82.0 10 Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence. Brain, behavior, & immunity - health 80.0 11 Benzimidazole as a Versatile Scaffold for Developing Neurotherapeutics Against Neurodegenerative Diseases. ChemMedChem 74.0 12 Biomimicking neuromelanin reverses the gait deficits and dopaminergic neuronal loss in the Parkinson's disease. Colloids and surfaces. B, Biointerfaces 86.0 13 Neuroprotective roles of klotho: Molecular pathways and therapeutic implications for cognitive health in neurological and psychiatric diseases. Experimental physiology 84.0 14 Flavonoid Rutin Reduces Intestinal Inflammation in an Experimental Model of Parkinson's Disease. Neurotoxicity research 70.0 15 Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy. Molecular pharmaceutics 78.0 16 Pathophysiological Role of the Gut Brain Axis in Parkinson's Disease: From Microbial Metabolites and Intestinal Permeability to Central Neuroinflammation. Current neurovascular research 86.0 17 Parkinson's Disease: From Metabolism to Genetics-A Comprehensive Review. Current issues in molecular biology 86.0 18 Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders. Neuroprotection (Chichester, England) 76.0 19 Integrative network pharmacology delineates dual GPCR and non-GPCR mechanisms of blended and individual Taikong Blue lavender and Pingyin rose essential oils in neurodegenerative and psychiatric disorders. Computers in biology and medicine 65.0 20 Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets. Experimental neurology 78.0 21 Hyaluronic acid: emerging roles and biomaterial innovations in Alzheimer's and Parkinson's disease therapy. Frontiers in pharmacology 75.2 22 Molecular mechanisms underlying Parkinson's disease and role of phytochemicals, α-synuclein, sirtuins, and incretin mimetics in potential therapy. Frontiers in pharmacology 75.0 23 Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities. Cell death discovery 82.0 24 Brain-gut-microbiota axis: a review on the bidirectional regulatory mechanisms between gut microbiota and brain and their disease interactions. Frontiers in microbiology 74.0 25 Long non-coding RNAs in neurodegenerative diseases - Molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: A review. Biomolecules & biomedicine 84.0 26 Neurosyphilis and Parkinsonism: Overlapping Pathophysiology and Emerging Therapeutic Insights. Current neurovascular research 76.0 27 Molecular biochemistry of soluble epoxide hydrolase in lipid mediator pathways and neuroinflammatory responses. The Journal of steroid biochemistry and molecular biology 82.0 28 Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential. Cell stress 83.3 29 Neuroprotective Role of Exercise-based Physiotherapy Combined with Pharmacological Agents in Parkinson's Disease. Central nervous system agents in medicinal chemistry 64.0 30 Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. Signal transduction and targeted therapy 84.0 31 HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches. Inflammopharmacology 78.0 32 Beyond acid-base dyshomeostasis: Dynamic instability of neuronal lysosomal pH as a pathogenic mechanism and therapeutic target in neurological diseases. Biochemical pharmacology 88.0
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic